Understanding how our genetic make-up is linked to our risk of developing a neurodegenerative disorder such as dementia, and how it influences disease progression, could be key to developing new treatments. However, the diseases that cause dementia are extremely complex, ..
In the beginning of this year, Pfizer, the third largest pharmaceutical company in the world, announced that it would end its neuroscience discovery programme, effectively ending all research into finding new treatments for dementia. This has come as a shock ..
Over 10 years ago the last drug for use in people with Alzheimer’s Disease was licensed. As there are still no treatments to halt or cure the disease, the search for treatment continues. In this blog, we will explore the ..